Biotech in Brasil Cluster Minas Gerais V Seminário de Negócios
Biotechnology Brasil
Biotechnology Brasil The Brazil stands out, along with Russia, India, China and South Africa, as a major emerging country of the first decade of the 21st century. Since 1990, the country has experienced steady GDP growth of around 3% per year, with a slight dip in 2012, when growth was 0.9%. Several government institutions such as BNDES, FINEP and others have supported and invested in Brazil. The Ministry of Science, Technology and Innovation and the Ministry of Development, Industry and Foreign Trade have been very active in implementing policies of national innovation.
Biotechnology Brasil
Biotechnology Minas Gerais
Contexto Econômico Economic Context Fonte: PBH
Biotechnology Minas Gerais Minas Gerais is the second largest economy in the country, with growth rates above the national average. The Government of Minas prioritizes investments in the production and development of Minas Gerais Technology Park - making the state one of the most innovative Latin America. Government of Minas put the sector of biotechnology and life sciences as one of the main axes of work and investment. + 200 manufacturing Biotech and Life Sciences companies.
Biotechnology Minas Gerais Technological Incubators: Inova (UFMG), Habitat (Biominas), INCIT,...; Very good Universities: UFMG, Ciências Médicas, PUC Minas. Research Centers (EMBRAPA, CETEC, FUNED, FIOCRUZ/RR). Ezequiel Dias Foundation - FUNED
EZEQUIEL DIAS FOUNDATION (FUNED) State Institution linked to Minas Gerais Health Department FUNED is aligning SUS (National Health System) policies - Domestic production of drugs currently imported by the government. FUNED is a major supplier for Ministry of Health and MG for Pharma Medicines and Serum (snakes, tetanus, etc).
Policies for foreign investments Ranking Incentive for investments Policies for foreign capital Source: Unidade de Inteligência da Economist, Veja Abril (2012)
AMBIOTEC Minas Gerais Bioindustry Association
The Governance of Biotech Cluster AMBIOTEC is a Private and non-profit Association; Located in Technological Park BHTEC; Created in 2010 by biotech companies; more than 40 members manufacturers of products and services in the areas of human, animal and environment; Generate annual turnover of US$ 700 million (more than 2 billion Reais). Technologial Park Belo Horizonte - BHTEC
Business Environment Business Environment Fonte: Belotur
Cluster: Products and Services HUMAN HEALTH Molecular Diagnostics; Diagnostic kits and reagents for clinical analysis; Bone and tissue reconstruction; Injectable drugs and pharmaceuticals; Reagents for rapid tests; Production of synthetic antibodies; Proccess optimization automation equipments; Medical devices; Laboratory Control.
Cluster: Products and Services ANIMAL HEALTH AND AGRIBUSINESS Animal genetics diagnostics by DNA; Animal and plant genetic breeding; Injectable medicine. ENVIRONMENT Consulting services; Microbiological and physico-chemical tests
Companies at the Belo Horizonte area: Medical Devices Companies certified and registered at ANVISA
Opportunity in the Brazilian and South America Market
The Summary Entrepreneurs background/career Company history Company profile Products Sales activities Growing strategy Commercial projections Strengths / Company organization / Our offer Shareholders and strategic alliances Contacts
Founder and CEO of Celer Biotecnologia S/A Background/Career Mr. Denilson Laudares Rodrigues Electrical Engineering (1993) Pontifical Catholic University of MG PUC Minas MSc Mechatronics (1997) Aeronautics Technological Institute ITA Ph.D. Computer Science (2002) Federal University of MG UFMG University of Pennsylvania UPENN U.S. Part-time professor at PUC Minas
Background/Career Mr. Andreas Flugs Industrial Engineering and Management MSc Ilmenau University of Technology Germany (1998) CEO of BERATA GmbH, Altran Affiliate, Munich, Germany, (2000-2005) Senior Consultant of BeOne München GmbH, Munich, Germany, (2005-2008) COO of CELER, Brazil (2009)
Background/Career Mr. Rafael Vilarinhos Regional Sales Manager BIOBRAS (2002-2008) National Sales Manager PRODIMOL / ALERE (2008-2012) Business Administration Unopar Brazil (2012) CCO of CELER, Brazil (2012)
The Company MISSION Provide high technology in customizable solutions to optimize process to the heath sector. VISION Become the leading reference in the Latin America market as a supplier of innovative solutions to improve the human health.
History Timeline AFE and Initial Registrations Microplate Reader and Washer; Tax Benefits New Partner and Business Model Portfolio expansion and new opportunities 2008 2009 2010 2011 2012 2013 2014 2015 Invested by CRIATEC Semiautomatic Biochemistry GMP (CBPF) for instruments manufacturing New registers; GMP for Consumables; Importer and Distributer
The Company Develops and produces instruments for automation in clinical diagnosis. Multi skilled technical staff. Close connections with universities, research centers and companies in clinical diagnostics. Partner of BNDES (CRIATEC Fund) Local regulations ANVISA CBPF (GMP).
Our distribution network Distribution network Celer has a wide network of Distributors that covers all regions of Brazil. This Network includes 34 Distributors witch are attending the private market as well as the public sector and two commercial representants to serve the North and Northeast. Beside of the distribution network CELER participates direct on public tenders.
Commerce of CELER Strategy 1 Current portfolio New partner Production in house BS, EE, EV BA, EA, QL,.. Other possibilities FINAL CLIENT Laboratories International Partner Equip. + Reagents Netw. Of Dist. Lab. Research Lab. diagnostic Re-Sales 2 Agents National Partner OEM Export Distributors Service for technical assistant 3
CELER`s Strengths CBPF ANVISA certificated production system Certification of good manufacturing practices. BDNDES payment card Payments of national products/instruments with up to 48 rates. CELER is receiving the payment on time. NBC T19,41 CELER is audited once per year for good governance practices. CELER received public investment and is, because of this, always in favor of public institutions, specific in registration of products within ANVISA. With the law nr. 12.349, CELER has a major competitiveness to gain public tenders while the state has to prefer national products for public tenders.
Our offer CELER offers you OEM production at the best quality level and the Implementation with a strong R&D team (PhD and Masters). CELER operate for you a strong distribution network to serve the market of BRAZIL and SOUTH AMERICA. CELER is open for direct or indirect business participation. Familiarity with management of equipment/instruments productive processes for greater degree of complexity. Investment Fund Governmental (BNDES) Partnership, which provides differentiated treatment in all levels of government processes and opportunities for future investments.
Strategic Alliances
Contacts Denilson Laudares Rodrigues denilsonlr@celer.ind.br +55 31 9302-1082 Andreas Flugs aflugs@celer.ind.br +55 31 8429-2868 Rafael Vilarinhos Rafael.vilarinhos@celer.ind.br +55 31 9165-1308 www.celer.ind.br Rua Padre Eustáquio, 1133 subloja 11 Belo Horizonte MG ZIP 30710.580 Brazil Phone +55 31 3413-0814
Thank you! Denilson Laudares Rodrigues Conselheiro AMBIOTEC ambiotec@ambiotec.org.br www.ambiotec.org.br +55 31 3401-1125